ClearPoint Neuro (CLPT) Shares Outstanding (Diluted Average) (2013 - 2026)

ClearPoint Neuro has disclosed Shares Outstanding (Diluted Average) across 9 years of filings, most recently posting $29.5 million for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $29.5 million, up 6.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $29.5 million (up 6.59% YoY), and the FY2025 annual result was $28.3 million, up 4.76% from the prior year.
• Shares Outstanding (Diluted Average) came in at $29.5 million for Q1 2026 at ClearPoint Neuro, up from $28.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $29.5 million in Q1 2026 to a low of $23.7 million in Q1 2022.
• The 5-year median for Shares Outstanding (Diluted Average) is $25.5 million (2024), against an average of $26.2 million.
• Across the five-year window, Shares Outstanding (Diluted Average) climbed 25.62% in 2022 and climbed 0.54% in 2023, its largest moves.
• ClearPoint Neuro's Shares Outstanding (Diluted Average) stood at $24.2 million in 2022, then gained by 1.75% to $24.6 million in 2023, then rose by 9.85% to $27.0 million in 2024, then grew by 4.76% to $28.3 million in 2025, then increased by 4.35% to $29.5 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $29.5 million (Q1 2026), $28.3 million (Q4 2025), and $28.4 million (Q3 2025), per Business Quant data.